Log in
Enquire now
‌

US Patent 7612181 Dual variable domain immunoglobulin and uses thereof

Patent 7612181 was granted and assigned to Abbott on November, 2009 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
Current Assignee
Abbott
Abbott
Date Filed
August 18, 2006
Date of Patent
November 3, 2009
Patent Application Number
11507050
Patent Citations Received
‌
US Patent 12134658 Materials and methods for multidirectional biotransportation in virotherapeutics
0
‌
US Patent 12084722 Methods of determining responsiveness to anti-TNFα therapy in inflammatory bowel disease
0
‌
US Patent 12110338 Site-specific antibody-drug conjugation through glycoengineering
0
‌
US Patent 12115191 Methods of treating age-related and inflammatory diseases
0
‌
US Patent 11672826 Methods of treating aging-related disorders
0
‌
US Patent 11692042 Anti-CD73 antibodies and methods of use thereof
0
‌
US Patent 11697690 Site-specific glycoengineering of targeting moieties
0
‌
US Patent 11697801 AAV-mediated delivery of therapeutic antibodies to the inner ear
0
‌
US Patent 11753469 Methods of using bispecific CD33 and CD3 binding proteins
‌
US Patent 11759527 Anti-EGFR antibody-drug conjugates
•••
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
7612181
Patent Primary Examiner
‌
David J Blanchard

Find more entities like US Patent 7612181 Dual variable domain immunoglobulin and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.